MP, M., R, P., JB, E., L, R., S, E., & PS, S. (2024). Cancer treatment-induced ulcerative mucositis serves as a significant predictor of burden of illness including dysphagia, and associated disparities among hospitalized cancer patients. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 33(1), 22. https://doi.org/10.1007/s00520-024-09071-4
Chicago Style (17th ed.) CitationMP, Mohan, Pili R, Epstein JB, Rudin L, Eichhorn S, and Satheeshkumar PS. "Cancer Treatment-induced Ulcerative Mucositis Serves as a Significant Predictor of Burden of Illness Including Dysphagia, and Associated Disparities Among Hospitalized Cancer Patients." Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer 33, no. 1 (2024): 22. https://doi.org/10.1007/s00520-024-09071-4.
MLA (9th ed.) CitationMP, Mohan, et al. "Cancer Treatment-induced Ulcerative Mucositis Serves as a Significant Predictor of Burden of Illness Including Dysphagia, and Associated Disparities Among Hospitalized Cancer Patients." Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer, vol. 33, no. 1, 2024, p. 22, https://doi.org/10.1007/s00520-024-09071-4.
